USP39 Regulates the Cell Cycle, Survival, and Growth of Human Leukemia Cells

Overview

Journal Biosci Rep

Specialty Cell Biology

Date 2019 Mar 23

PMID 30898977

Citations 7

Authors

Chunxia Liu

Xiaojian Yao

Ming Li

Yaming Xi

Li Zhao

Affiliations

Soon will be listed here.

Abstract

Ubiquitin-specific peptidase 39 (USP39) is one member of the cysteine proteases of the USP family, which represents the largest group of DeUbiquitinases with more than 50 members in humans. The roles of USP39 in human cancer have been widely investigated. However, the roles of USP39 in human leukemia and the underlying mechanism remain unknown. Here we reported the function of USP39 in human leukemia. We observed that the expression of was up-regulated in human leukemia cells and the high expression of was correlated with poor survival of the patients with leukemia. Lentivirus-mediated knockdown of repressed the proliferation and colony formation of human leukemia cell lines HL-60 and Jurkat cells. Mechanism study showed that knockdown induced the arrest of cell cycle and apoptosis of leukemia cells. In addition, our microarray and bioinformatic analysis demonstrated that USP39 regulated diverse cellular signaling pathways that were involved in tumor biology, and several pivotal genes (, and ) have been validated by quantitative real-time polymerase chain reaction. Knockdown or partially restored the proliferation rate of leukemia cells with knockdown. Taken together, our findings implicate that USP39 promotes the development of human leukemia by regulating cell cycle, survival, and proliferation of the cells.

Citing Articles

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Microenvironment Infiltration and Drug Sensitivity in Breast Cancer.

Ma H, Cao J, Zhang Y, Yang J, Wang X, Yu Y J Cancer. 2025; 16(3):784-801.

PMID: 39781342 PMC: 11705054. DOI: 10.7150/jca.101525.

USP39 regulates pyruvate handling in non-small cell lung cancer.

Becirovic T, Zhang B, Vakifahmetoglu-Norberg H, Kaminskyy V, Kochetkova E, Norberg E Cell Death Discov. 2024; 10(1):502.

PMID: 39695108 PMC: 11655846. DOI: 10.1038/s41420-024-02264-0.

Ubiquitin-specific proteases (USPs) in leukemia: a systematic review.

Zangooie A, Tavoosi S, Arabhosseini M, Halimi A, Zangooie H, Baghsheikhi A BMC Cancer. 2024; 24(1):894.

PMID: 39048945 PMC: 11270844. DOI: 10.1186/s12885-024-12614-x.

Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis.

Zhang X, Jin J, Cong J, Chen S, Wang T, Gao B Curr Top Med Chem. 2024; 24(3):179-191.

PMID: 38173207 DOI: 10.2174/0115680266279228231219101233.

The roles of ubiquitination in AML.

Wei Z, Su L, Gao S Ann Hematol. 2023; 103(9):3413-3428.

PMID: 37603061 DOI: 10.1007/s00277-023-05415-y.

References

Xing Z, Sun F, He W, Wang Z, Song X, Zhang F . Downregulation of ubiquitin-specific peptidase 39 suppresses the proliferation and induces the apoptosis of human colorectal cancer cells. Oncol Lett. 2018; 15(4):5443-5450. PMC: 5844003. DOI: 10.3892/ol.2018.8061. View

Hourigan C, Gale R, Gormley N, Ossenkoppele G, Walter R . Measurable residual disease testing in acute myeloid leukaemia. Leukemia. 2017; 31(7):1482-1490. DOI: 10.1038/leu.2017.113. View

Dzneladze I, He R, Woolley J, Son M, Sharobim M, Greenberg S . INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia. Leukemia. 2015; 29(7):1485-95. DOI: 10.1038/leu.2015.51. View

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Greaves M . Leukaemia 'firsts' in cancer research and treatment. Nat Rev Cancer. 2016; 16(3):163-72. DOI: 10.1038/nrc.2016.3. View

Fraile J, Manchado E, Lujambio A, Quesada V, Campos-Iglesias D, Webb T . USP39 Deubiquitinase Is Essential for Oncogene-driven Cancer. J Biol Chem. 2017; 292(10):4164-4175. PMC: 5354494. DOI: 10.1074/jbc.M116.762757. View

Agathanggelou A, Smith E, Davies N, Kwok M, Zlatanou A, Oldreive C . USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status. Blood. 2017; 130(2):156-166. DOI: 10.1182/blood-2016-12-758219. View

Jin Q, Martinez C, Arcipowski K, Zhu Y, Gutierrez-Diaz B, Wang K . USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia. Clin Cancer Res. 2018; 25(1):222-239. PMC: 6320313. DOI: 10.1158/1078-0432.CCR-18-1740. View

Zhang Y, van Deursen J, Galardy P . Overexpression of ubiquitin specific protease 44 (USP44) induces chromosomal instability and is frequently observed in human T-cell leukemia. PLoS One. 2011; 6(8):e23389. PMC: 3154946. DOI: 10.1371/journal.pone.0023389. View

10.

Gan Z, Han K, Lin S, Hu H, Shen Z, Min D . Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro. Biol Res. 2017; 50(1):15. PMC: 5389082. DOI: 10.1186/s40659-017-0121-z. View

11.

Cai J, Liu T, Huang P, Yan W, Guo C, Xiong L . USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway. Biochem Biophys Res Commun. 2017; 486(1):184-190. DOI: 10.1016/j.bbrc.2017.03.025. View

12.

Zhao Y, Zhang B, Lei Y, Sun J, Zhang Y, Yang S . Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma. Tumour Biol. 2016; 37(10):13167-13176. DOI: 10.1007/s13277-016-5212-x. View

13.

Yuan X, Sun X, Shi X, Wang H, Wu G, Jiang C . USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway. Oncol Rep. 2017; 37(4):2398-2404. DOI: 10.3892/or.2017.5454. View

14.

Huang Y, Pan X, Li L, Chen L, Liu X, Lu J . Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation. Oncotarget. 2016; 7(16):22016-30. PMC: 5008341. DOI: 10.18632/oncotarget.7882. View

15.

Li N, He Y, Wang L, Mo C, Zhang J, Zhang W . D-galactose induces necroptotic cell death in neuroblastoma cell lines. J Cell Biochem. 2011; 112(12):3834-44. DOI: 10.1002/jcb.23314. View

16.

Li L, Osdal T, Ho Y, Chun S, McDonald T, Agarwal P . SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell. 2014; 15(4):431-446. PMC: 4305398. DOI: 10.1016/j.stem.2014.08.001. View

17.

He S, Zhong W, Yin L, Wang Y, Qiu Z, Song G . High expression of ubiquitin-specific peptidase 39 is associated with the development of vascular remodeling. Mol Med Rep. 2017; 15(5):2567-2573. PMC: 5428656. DOI: 10.3892/mmr.2017.6297. View

18.

van Leuken R, Luna-Vargas M, Sixma T, Wolthuis R, Medema R . Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. Cell Cycle. 2008; 7(17):2710-9. DOI: 10.4161/cc.7.17.6553. View

19.

Mistry H, Hsieh G, Buhrlage S, Huang M, Park E, Cuny G . Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol Cancer Ther. 2013; 12(12):2651-62. PMC: 4089878. DOI: 10.1158/1535-7163.MCT-13-0103-T. View

20.

Pan Z, Pan H, Zhang J, Yang Y, Liu H, Yang Y . Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro. Biol Res. 2015; 48:18. PMC: 4389921. DOI: 10.1186/s40659-015-0006-y. View